BALPHARMA.BO
Price:
$100.45
Market Cap:
$1.60B
Bal Pharma Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India, Uzbekistan, Guatemala, and Malta. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk actives. It provides anti-infectives, pain management, respiratory care, and women's health products under the Aziwin, Ebay, Balvibe, MNF, Ocium, and Monogesic Plus Gel brands; diabetic care products under the Diabend and Diabend M Group brands; herbal/ayurvedic preparations targeting conditions, such as prostate enlargement, renal calculi, male infertility, women health, etc. under the Stonex, Ashwamed, Prostowin, Suswas, Menoleap,...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2002-01-02
Stock Exchange
BSE
Ticker
BALPHARMA.BO
According to Bal Pharma Limited’s latest financial reports and current stock price. The company's current ROE is 10.14%. This represents a change of 355.17% compared to the average of 2.23% of the last 4 quarters.
The mean historical ROE of Bal Pharma Limited over the last ten years is 3.48%. The current 10.14% ROE has changed 191.15% with respect to the historical average. Over the past ten years (40 quarters), BALPHARMA.BO's ROE was at its highest in in the March 2024 quarter at 7.90%. The ROE was at its lowest in in the March 2020 quarter at -7.75%.
Average
3.48%
Median
4.98%
Minimum
-23.31%
Maximum
10.67%
Discovering the peaks and valleys of Bal Pharma Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 164.60%
Maximum Annual ROE = 10.67%
Minimum Annual Increase = -510.03%
Minimum Annual ROE = -23.31%
Year | ROE | Change |
---|---|---|
2025 | 9.32% | -12.63% |
2024 | 10.67% | 164.60% |
2023 | 4.03% | -57.88% |
2022 | 9.57% | 8.15% |
2021 | 8.85% | -137.98% |
2020 | -23.31% | -510.03% |
2019 | 5.68% | 32.77% |
2018 | 4.28% | 35.77% |
2017 | 3.15% | 23.18% |
2016 | 2.56% | -61.05% |
The current ROE of Bal Pharma Limited (BALPHARMA.BO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
8.01%
5-year avg
8.49%
10-year avg
3.48%
Bal Pharma Limited’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bal Pharma Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bal Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Bal Pharma Limited's ROE?
How is the ROE calculated for Bal Pharma Limited (BALPHARMA.BO)?
What is the highest ROE for Bal Pharma Limited (BALPHARMA.BO)?
What is the 3-year average ROE for Bal Pharma Limited (BALPHARMA.BO)?
What is the 5-year average ROE for Bal Pharma Limited (BALPHARMA.BO)?
How does the current ROE for Bal Pharma Limited (BALPHARMA.BO) compare to its historical average?